Acorda Therapeutics, Inc.

OTCPK:ACOR.Q 주식 보고서

시가총액: US$37.4k

Acorda Therapeutics 관리

관리 기준 확인 2/4

Acorda Therapeutics CEO는 Ron Cohen, Jan1995 에 임명되었습니다 의 임기는 29.58 년입니다. 총 연간 보상은 $ 996.33K, 62.7% 로 구성됩니다. 62.7% 급여 및 37.3% 보너스(회사 주식 및 옵션 포함). 는 $ 225.39 가치에 해당하는 회사 주식의 0.6% 직접 소유합니다. 225.39. 경영진과 이사회의 평균 재임 기간은 각각 6.3 년과 21.1 년입니다.

주요 정보

Ron Cohen

최고 경영자

US$996.3k

총 보상

CEO 급여 비율62.7%
CEO 임기29.6yrs
CEO 소유권0.6%
경영진 평균 재임 기간6.3yrs
이사회 평균 재임 기간21.1yrs

최근 관리 업데이트

Shareholders May Be More Conservative With Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) CEO Compensation For Now

May 26
Shareholders May Be More Conservative With Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) CEO Compensation For Now

Recent updates

Health Check: How Prudently Does Acorda Therapeutics (NASDAQ:ACOR) Use Debt?

Feb 21
Health Check: How Prudently Does Acorda Therapeutics (NASDAQ:ACOR) Use Debt?

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Surges 53% Yet Its Low P/S Is No Reason For Excitement

Dec 18
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Surges 53% Yet Its Low P/S Is No Reason For Excitement

Is Acorda Therapeutics (NASDAQ:ACOR) Using Debt Sensibly?

Jun 05
Is Acorda Therapeutics (NASDAQ:ACOR) Using Debt Sensibly?

Acorda wins $16.5M in Ampyra arbitration case with Alkermes

Oct 17

Acorda stock rise 11% as proposal to increase shares withdrawn; reverse split still on vote

Oct 10

Acorda inks license deal with Asieris for pre-clinical drug

Aug 29

Acorda Therapeutics announces resignation of COO

Aug 19

Acorda Therapeutics: Managing The Transition

Oct 04

Acorda Therapeutics Continues To Maneuver For A Turnaround

Jul 24

CureVac downgraded following COVID vaccine data, Regeneron COVID cocktail a boon, and more in analyst action

Jun 17

Shareholders May Be More Conservative With Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) CEO Compensation For Now

May 26
Shareholders May Be More Conservative With Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) CEO Compensation For Now

Acorda Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Sole Analyst Just Made A Huge Upgrade To Their Forecasts

Mar 09
Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Sole Analyst Just Made A Huge Upgrade To Their Forecasts

CEO 보상 분석

Ron Cohen 의 보수는 Acorda Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$263m

Dec 31 2023US$996kUS$625k

-US$253m

Sep 30 2023n/an/a

-US$16m

Jun 30 2023n/an/a

-US$21m

Mar 31 2023n/an/a

-US$58m

Dec 31 2022US$984kUS$625k

-US$66m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$119m

Mar 31 2022n/an/a

-US$95m

Dec 31 2021US$2mUS$743k

-US$104m

Sep 30 2021n/an/a

-US$166m

Jun 30 2021n/an/a

-US$132m

Mar 31 2021n/an/a

-US$127m

Dec 31 2020US$2mUS$796k

-US$100m

Sep 30 2020n/an/a

US$49m

Jun 30 2020n/an/a

-US$222m

Mar 31 2020n/an/a

-US$232m

Dec 31 2019US$2mUS$796k

-US$273m

Sep 30 2019n/an/a

-US$329m

Jun 30 2019n/an/a

-US$79m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$2mUS$796k

US$34m

Sep 30 2018n/an/a

-US$147m

Jun 30 2018n/an/a

-US$158m

Mar 31 2018n/an/a

-US$213m

Dec 31 2017US$2mUS$792k

-US$223m

보상 대 시장: Ron 의 총 보상 ($USD 996.33K )은 US 시장( $USD 646.00K ).

보상과 수익: 회사가 수익성이 없는 동안 Ron 의 보상이 증가했습니다.

CEO

Ron Cohen (68 yo)

29.6yrs

테뉴어

US$996,328

보상

Dr. Ron Cohen, M.D., serves as an Independent Director of ZWI Therapeutics, Inc. since January 2024. He has been the Founder of Acorda Therapeutics, Inc. since 1995 and has been its Chief Executive Officer...

리더십 팀

이름위치테뉴어보상소유권
Ron Cohen
Founder29.6yrsUS$996.33k0.60%
$ 225.4
Michael Gesser
CFO & Treasurer2.8yrsUS$611.55k0%
$ 0
Neil Belloff
General Counsel & Corporate Secretary2.8yrsUS$661.57k0%
$ 0
Denise Duca
Executive Vice President of Human Resources9.6yrs데이터 없음데이터 없음
Kerry Clem
Chief Commercial Officer2.9yrsUS$592.23k0.041%
$ 15.2
Sofia Ali
Senior VP of Operations & Strategic Planningno data데이터 없음데이터 없음
Susan Way
Senior VP of Drug Development & Regulatory Affairsno data데이터 없음데이터 없음
Wise Young
Special Scientific Advisorno dataUS$10.00k데이터 없음

6.3yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 관리: ACOR.Q 의 관리팀은 노련하고 경험 (평균 재직 기간 6.3 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Ron Cohen
Founder29.6yrsUS$996.33k0.60%
$ 225.4
John Varian
Independent Director2.6yrsUS$94.71k0%
$ 0
Carl Cotman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Sandra Panem
Independent Director26.6yrsUS$82.65k0.0019%
$ 0.7
Mark Tuszynski
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Melitta Schachner
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Patrick Tresco
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Stephen Waxman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Mary Bunge
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
James Fawcett
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Beattie
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
John Kelley
Independent Non-Executive Chairman15.7yrsUS$140.22k0%
$ 0

21.1yrs

평균 재임 기간

70yo

평균 연령

경험이 풍부한 이사회: ACOR.Q 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 21.1 년).